第六批高值医用耗材国家集采开标

Core Viewpoint - The sixth batch of centralized procurement for high-value medical consumables was opened for bidding in Tianjin, with results expected to be announced on January 14. This procurement aims to stabilize clinical practices, ensure quality, and prevent price undercutting in the industry [1]. Group 1: Procurement Details - The procurement includes 12 types of medical consumables, covering drug-coated balloons and urological intervention products. For instance, the annual demand for drug-coated balloons in medical institutions is approximately 610,000 units [1]. - The urological intervention consumables, which are used for kidney stones and ureteral stones, represent a previously unaddressed area in centralized procurement, with eight products included in this batch [1]. Group 2: Principles and Regulations - The procurement process is guided by principles aimed at stabilizing clinical practices, ensuring quality, preventing excessive competition, and avoiding price undercutting. This is the first time the term "preventing excessive competition" has been mentioned in the context of consumables [1]. - The National Healthcare Security Administration has set a procurement cycle of three years, during which medical institutions are required to prioritize the purchase and use of the selected products and ensure timely payments according to the procurement agreements [1].